Literature DB >> 32301030

Platelet-to-lymphocyte ratio relates to poor prognosis in elderly patients with acute myocardial infarction.

Li Li1, Yi Ma2, Xue-Bin Geng1, Zheng Tan1, Jian-Hui Wang1, Chuan Cui1, Hong-Ling Wang1, Xiao-Ming Shang1.   

Abstract

BACKGROUND: The platelet to lymphocyte ratio (PLR) is a novel biomarker to predict the prognosis of acute myocardial infarction (AMI) patients. AIM: The study aimed to evaluate the in-hospital outcomes of elderly patients with AMI and assessed the prognostic value of PLR on in-hospital adverse events.
METHODS: A total of 1,001 patients were divided into an older group (n = 560) and a younger group (n = 441) based on age ≥ 60 years and successfully underwent primary percutaneous coronary intervention (PCI) within 12 h after presentation. Total white blood cells (WBCs), neutrophils, lymphocytes, and platelets counts were measured at admission.
RESULTS: The incidence of heart rupture, acute heart failure, total adverse events, and death resulting from all events were significantly higher in patients ≥ 60 years than in younger patients, whereas the incidence of postoperative angina and reinfarction were similar between groups. Regarding blood counts, total white blood cells, neutrophils, lymphocytes, and platelets were lower in the older group than in the younger group. The platelet-to-lymphocyte ratio (PLR) was significantly higher in the older group. In receiver operating characteristic curve analysis, high PLR > 147 predicted adverse events (specificity 72% and sensitivity 63%). In multiple logistic regression analysis, age, hypertension, and PLR were identified as independent predictors of adverse events.
CONCLUSIONS: The in-hospital outcomes of elderly patients with acute myocardial infarction were poor. PLR was an independent risk factor for in-hospital adverse events, which suggested that strong inflammation and prothrombotic status may contribute to the poor prognoses of elderly patients.

Entities:  

Keywords:  Acute myocardial infarction; Age; In-hospital outcomes; Platelet-to-lymphocyte ratio; Prognostic factors

Year:  2020        PMID: 32301030     DOI: 10.1007/s40520-020-01555-7

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

1.  Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.

Authors:  Andrzej Ciszewski; Maciej Karcz; Cezary Kepka; Paweł Bekta; Ewa Ksiezycka; Jakub Przyłuski; Artur Debski; Adam Witkowski; Witold Ruzyłło
Journal:  Kardiol Pol       Date:  2008-08       Impact factor: 3.108

Review 2.  Correlation of platelet count and acute ST-elevation in myocardial infarction.

Authors:  G K Paul; B Sen; M A Bari; Z Rahman; F Jamal; M S Bari; S R Sazidur
Journal:  Mymensingh Med J       Date:  2010-07
  2 in total
  5 in total

1.  Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients.

Authors:  Qiuxuan Li; Xiaoteng Ma; Qiaoyu Shao; Zhiqiang Yang; Yufei Wang; Fei Gao; Yujie Zhou; Lixia Yang; Zhijian Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-03

2.  A New Risk Predictor in Acute Myocardial Infarction. Is There Still Room for One More?

Authors:  Dalton Bertolim Précoma
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

3.  The Novel Predictive Biomarkers for Type 2 Diabetes Mellitus in Active Pulmonary Tuberculosis Patients.

Authors:  Qi Yu; Wujin Weng; Hong Luo; Jisong Yan; Xin Zhao
Journal:  Infect Drug Resist       Date:  2022-08-13       Impact factor: 4.177

4.  A scoring system developed from a nomogram to differentiate active pulmonary tuberculosis from inactive pulmonary tuberculosis.

Authors:  Qi Yu; Jisong Yan; Shan Tian; Wujin Weng; Hong Luo; Gang Wei; Gangyu Long; Jun Ma; Fengyun Gong; Xiaorong Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-02       Impact factor: 6.073

5.  Systemic Immune-Inflammation Index Predicts Major Cardiovascular Adverse Events in Patients with ST-Segment Elevated Myocardial Infarction.

Authors:  Faysal Saylik; Tayyar Akbulut
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.